Get started
Author

Patricia García Ramírez

Observed names: P. García Ramírez, P. García‐Ramirez, Patricia Garcia Ramirez, Patricia García Ramirez, Patricia García-Ramírez, Patricia García Ramírez, Patricia García‐Ramírez
Observed institutions: Universidad de Alcalá, Complejo Hospitalario de Navarra, Hospital Universitario Príncipe de Asturias, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Universidad de Sevilla
ORCID: 0000-0003-1471-5018
Observed ORCID: 0000-0003-1471-5018
OpenAlex ID: A5089100491
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
2019 · Carmen Vicente, Elena Arriazu, et al. · Cancer Letters · 42
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia
2020 · Elena Arriazu, Carmen Vicente, et al. · Blood Cancer Journal · 37
PDF
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
2024 · Joaquín Martínez-López, Javier de la Cruz, et al. · Cancers · 8
PDF
Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients
2022 · Patricia García Ramírez, Lucía Castilla García, et al. · Medicina Clínica (English Edition) · 4
SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment
2024 · Patricia García Ramírez, Marta Callejas Charavia, et al. · Vaccines · 2
PDF
Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone ( Dara‐VRD ): Striking response with no washout in a newly diagnosed multiple myeloma
2024 · Juan José Gil‐Fernández, Patricia García Ramírez, et al. · Clinical Case Reports · 2
PDF
[Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients].
2022 · Patricia García Ramírez, Lucía Castilla García, et al. · PubMed · 2
Recaída de la púrpura trombocitopénica inmune tras la vacunación frente al SARS-CoV-2
2021 · Patricia García Ramírez, Lucía Castilla García, et al. · Medicina Clínica · 2
PDF
Clasificación de las enfermedades del hematíe. Síndrome anémico y poliglobúlico. Concepto y clasificación
2020 · P. Villafuerte Gutiérrez, P. García Ramírez · Medicine - Programa de Formación Médica Continuada Acreditado · 2
Real‐World Outcomes of FLAG ‐Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML : A PETHEMA Study
2026 · Gaspar Aspas Requena, Rebeca Rodríguez‐Veiga, et al. · American Journal of Hematology · 1
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry
2026 · Jon Salmanton-García, Francesco Marchesi, et al. · Open Forum Infectious Diseases · 1
Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
2023 · Cristina Andrés-Zayas, Julia Suárez-González, et al. · Cancers · 1
PDF
Protocolo diagnóstico y terapéutico de las poliglobulias
2020 · P. García Ramírez, P. Villafuerte Gutiérrez · Medicine - Programa de Formación Médica Continuada Acreditado · 1
Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval
2018 · Eduardo Rodríguez-Arbolí, Francisco José Márquez-Malaver, et al. · Transplantation and Cellular Therapy · 1
PDF
High Mortality Associated with Neurological Complications after Allogeneic Stem Cell Transplantation
2014 · Sara Lozano, Amaya Zabalza, et al. · Blood · 1
Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia
2026 · Sarah Bertoli, Niklas Landberg, et al. · Blood
Successful Early Rescue with Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients with “No Washout Period”: A Real-World Clinical Experience in A Case Series and Literature Review
2026 · Paula Gili Herreros, Patricia García Ramírez, et al. · Archives of Clinical and Medical Case Reports
PDF
The addition of a tyrosine kinase inhibitor to intensive chemotherapy significantly improves outcome in de novo BCR::ABL1+ acute myeloid leukemia treated with intensive chemotherapy
2025 · Sarah Bertoli, Niklas Landberg, et al. · Blood
Daratumumab as Post-Asct Maintenance in Multiple Myeloma Patients with Lenalidomide Intolerance/Toxicity: Results From a Single Center Over the Last 5 Years
2025 · Paula GIli Herreros, María Menor Gómez, et al. · Clinical Lymphoma Myeloma & Leukemia
Optimization of Post-Autologous Hematopoietic Stem Cell Transplant (Asct) Maintenance Therapy in Multiple Myeloma (Mm): Analysis of a Single-Center’s Results Over the Last 5 Years
2025 · María Menor Gómez, Paula Gili Herreros, et al. · Clinical Lymphoma Myeloma & Leukemia
Leucemias agudas
2024 · P. García Ramírez, P.A. Rodríguez Barquero, et al. · Medicine - Programa de Formación Médica Continuada Acreditado
Varón de 71 años pluripatológico que consulta por bicitopenia
2024 · M. Callejas Charavía, P. García Ramírez · Medicine - Programa de Formación Médica Continuada Acreditado
Impact of early palliative care intervention in autologous bone marrow transplantation: feasibility of a multicentric study
2024 · María Argüello-Marina, Marta Callejas-Charavía, et al. · BMC Palliative Care
PDF
Pb2676: Are Novel Therapeutic Opportunities Leading Us to Overtreat Patients?: a Review of End-of-life Situation in Haematological Patients
2023 · Celia Martinez Vázquez, Marta Callejas Charavia, et al. · HemaSphere
Effectiveness of an Antifungal Stewardship Program in a Hematology Ward at a Madrid Teaching Hospital: The Time Is Now
2022 · Maria Arguello, Lucía Castilla García, et al. · Blood
Works count: 30
Citation count: 107
H-index: 4
I10-index: 2
Year
Topic
Type